The present invention relates to the use of beta-(1, 3)- beta-(1, 4) glucan with an average molecular weight of from 5.000 to 150.000 da for the increase of synthesis of collagen
Non-therapeutic use, of beta-(1,3)-beta-(1,4) glucan with a mean molecular weight of from 5.000 to 150.000 Da, preferably 13.000 to 60.000 Da, particularly 20.000 to 0.000 Da, for the increase of synthesis of collagen.